Education

Postdoctoral Fellow, Stanford University, 2021

Lab information

Dr. Wu earned her medical degree and a doctorate in clinical medicine at the West China Medical College in China. She received her first postdoc training at Smidt heart institute of Cedars Sinai medical center and focused on studying the endovascular inflammation and calcium regulation in HFpEF (Heart Failure with Preserved Ejection Fraction) and testing the efficacy of Cardiosphere-derived cells (CDCs) and their secreted exosomes (CDCexo) for heart failure. She comes to the Alexander Lab with expertise in calcium handling and cardiosphere-derived cell-based therapy in rodents models. Dr. Wu is currently leading our research efforts on studying the mechanisms underlying the development of transthyretin cardiac amyloidosis(ATTR). Her work using iPSC and animal models as well as human samples will undoubtedly lead to important insights into this deadly disease and improve outcomes for cardiac amyloid patients.

Research focus

Regenerative Medicine, Translational Medicine, Cell Biology, Molecular Biology, Stem cell, Tissue Engineering, Cardiovascular Diseases, Electrophysiology, AI and machine learning

Publications